KELLY PEREZ: Open Payments
NPI 1730412172 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,119 in 101 payments from 17 companies in 2025. Trend: 2023 $966 · 2024 $2,001 · 2025 $2,119
Food & beverage: $2,119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $449 |
| Madrigal Pharmaceuticals | 11 | $297 |
| Janssen Biotech, Inc. | 16 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $249 |
| Ardelyx, Inc. | 6 | $183 |
| GENZYME CORPORATION | 3 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| Regeneron Healthcare Solutions, Inc. | 4 | $76 |
| Aimmune Therapeutics, Inc. | 3 | $76 |
| PFIZER INC. | 4 | $68 |
Products named: REZDIFFRA, TREMFYA, ENTYVIO, DUPIXENT, IBSRELA, RINVOQ, LINZESS, SKYRIZI.
Industry payments across FL — which companies pay providers there.
